凝血指标在冠心病诊疗中的临床应用  

Clinical Application of Coagulation Index in Diagnosis and Treatment of Coronary Heart Disease

作　　者：范立雪[1] 

机构地区：[1]沈阳市第十人民医院临床检验中心,辽宁沈阳110044

出　　处：《中国医药指南》2017年第7期130-131,共2页Guide of China Medicine

摘　　要：目的研究凝血指标在冠心病诊疗中的临床应用的意义。方法选取在沈阳市第十人民医院,心血管一病房的冠心病患者100例,就诊时间在2014年6月至2015年6月以内,以及健康体检者100例,比较两组患者D-二聚体、Fib、PT、APTT值。结果试验组D-二聚体、Fib均高于对照组,差异有统计学意义(P<0.05),试验组PT均低于对照组,差异有统计学意义(P<0.05),两组患者的APTT之间没有差异(P>0.05)。结论 D-二聚体、Fib、PT与冠心病有密切相关,对于冠心病患者时刻关注这些指标,有助于冠心病的诊断和治疗。Objective To study the clinical application of coagulation index in the diagnosis and treatment of coronary heart disease. Methods Tenth patients with coronary heart disease in people＇s Hospital of Shenyang city, 100 patients with coronary heart disease, and 100 cases of healthy physical examination were compared with two groups of patients with Fib, PT, APTT and D-dimer values. Results The Fib and D-dimer in the experimental group were higher than those in the control group, the difference was statistically significant（P0.05）, the PT in the experimental group was lower than that in the control group, the difference was statistically significant（P0.05）, there was no difference between the two groups of patients（P0.05）. Conclusion Fib, PT, D-dimer and coronary heart disease are closely related, for patients with coronary heart disease, which is helpful to the diagnosis and treatment of coronary artery disease.

关 键 词：纤维蛋白原 抗凝血功能 

分 类 号：R541.4[医药卫生—心血管疾病]